Myhre–School syndrome
Myhre–School Syndrome is a rare genetic disorder characterized by a range of physical, developmental, and sometimes cognitive abnormalities. This syndrome is caused by mutations in the SMAD4 gene, which plays a crucial role in the transforming growth factor-beta (TGF-β) signaling pathway, a critical pathway for cell growth, proliferation, differentiation, and apoptosis.
Symptoms and Characteristics[edit | edit source]
Myhre–School Syndrome presents a spectrum of clinical features, including but not limited to:
- Growth abnormalities: Individuals may exhibit short stature, limited growth potential, and in some cases, obesity.
- Facial features: Distinctive facial characteristics such as a round face, deep-set eyes, and a small mouth with thin upper lips are common.
- Musculoskeletal issues: Patients often have muscle hypertrophy, joint stiffness, and limited joint mobility.
- Skin abnormalities: Thick skin and a reduction in the elasticity of the skin are noted in many cases.
- Hearing loss: Progressive sensorineural hearing loss can occur.
- Cognitive development: While intelligence can range from normal to mild intellectual disability, some individuals may experience learning difficulties.
- Cardiovascular anomalies: There is an increased risk of developing hypertension and other cardiovascular complications.
Diagnosis[edit | edit source]
Diagnosis of Myhre–School Syndrome is primarily based on clinical evaluation and the identification of characteristic features. Genetic testing confirming a mutation in the SMAD4 gene is crucial for a definitive diagnosis. Due to the rarity of the syndrome, diagnosis can be challenging and often requires a multidisciplinary approach.
Management and Treatment[edit | edit source]
There is no cure for Myhre–School Syndrome, and treatment is symptomatic and supportive. Management strategies may include:
- Growth monitoring: Regular assessment of growth and development is essential.
- Physiotherapy: To improve joint mobility and reduce muscle stiffness.
- Audiological assessments: Regular hearing tests and interventions, such as hearing aids, may be necessary.
- Cardiovascular monitoring: Regular check-ups to monitor and manage cardiovascular health.
- Educational support: Tailored educational programs may benefit those with learning difficulties.
Prognosis[edit | edit source]
The prognosis for individuals with Myhre–School Syndrome varies depending on the severity of symptoms and the effectiveness of management strategies. With appropriate care, most individuals can lead a relatively normal life, although they may face challenges related to their physical and cognitive symptoms.
Epidemiology[edit | edit source]
Myhre–School Syndrome is extremely rare, with only a small number of cases reported worldwide. It affects males and females equally.
Research Directions[edit | edit source]
Research into Myhre–School Syndrome is ongoing, with studies focusing on understanding the molecular mechanisms underlying the syndrome and exploring potential therapeutic targets within the TGF-β signaling pathway.
Myhre–School syndrome Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD